Finance

Beta
Lists
INMB:NASDAQ
INmune Bio Inc
$1.74
+4.50%
(+0.075) 1D
$1.72
-1.04% (-0.018)
After hours
Closed: Jul 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INMB...
Open
$1.67
High
$1.85
Low
$1.54
Mkt. cap
46.12M
Avg. vol.
895.57K
Volume
1.79M
52-wk high
$3.24
52-wk low
$1.09
EPS
-$1.69
Beta
0.97
Shares outstanding
26.58M
No. of employees
21
Open
$1.67
High
$1.85
Low
$1.54
Mkt. cap
46.12M
Avg. vol.
895.57K
Volume
1.79M
52-wk high
$3.24
52-wk low
$1.09
EPS
-$1.69
Beta
0.97
Shares outstanding
26.58M
No. of employees
21
News stories
From sources across the web
About INmune Bio Inc
CEO-
Employees21
Founded2015
HeadquartersBoca Raton, Florida, United States
SectorBiotechnology
Websiteinmunebio.com
Analyst ratings
Based on 1 analyst giving stock ratings to INMB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INMB in the last 3 months
Highest
Current $1.74
$8.00 (+359.77%)
Average
$8.00 (+359.77%)
Lowest
$8.00 (+359.77%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+359.8%
06/23/2026
James Molloy
Alliance Global Partners
Buy
Maintained
$7.00
+302.3%
04/06/2026
Elemer Piros
Lucid Capital
Buy
Upgraded
$9.00
+417.2%
03/11/2026
Thomas Shrader
BTIG
Hold
Maintained
-
-
11/03/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.80M
4.75M
2.56M
3.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.25M
2.68M
2.92M
2.17M
Operating expense
8.06M
7.43M
5.47M
5.81M
Total operating expenses
8.06M
7.43M
5.47M
5.81M
Operating income
-8.06M
-7.43M
-5.47M
-5.81M
Other non operating income
-
-39.00K
-90.00K
405.00K
EBT including unusual items
-24.46M
-6.47M
-5.26M
-5.41M
EBT excluding unusual items
-7.94M
-7.07M
-5.26M
-5.41M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24.46M
-6.47M
-5.26M
-5.41M
Net profit margin
-
-
-
-
Earnings per share
-0.34
-0.24
-0.18
-0.20
Interest and investment income
113.00K
400.00K
300.00K
-
Interest expense
-
-
-
-
Net interest expenses
113.00K
400.00K
300.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-7.42M
-5.42M
-5.76M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer